dr. mehanna on the design of the de-escalate trial in hpv head and neck cancer
Published 5 years ago • 151 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
1:50
dr. mehanna on the updated staging system for hpv head and neck cancer
-
1:17
dr. mehanna on implications of the updated staging system for hpv head and neck cancer
-
44:26
are we ready to de-escalate? treatment of hpv head and neck cancer
-
5:50
de-escalation of therapy for hpv-positive hnscc
-
1:40
dr. hisham mehanna on quality of life differences in head and neck squamous cell cancer
-
4:00
incorporating cetuximab in head and neck cancer treatment
-
2:48
optima ii: de-escalating therapy in hpv-positive oropharyngeal cancer
-
4:57
cetuximab for oropharyngeal cancer: latest data from de-escalate
-
1:23
evaluating options for hpv oropharyngeal cancer: cisplatin-rt vs. cetuximab-rt
-
1:01
erin mcmenamin on treatments for hpv-positive head and neck cancer
-
5:38
curable hpv negative head and neck cancer
-
8:56
cetuximab safety profile in head and neck cancer
-
8:10
de-escalating chemo-radiotherapy in locally advanced hpv oropharynx cancer
-
0:43
monitoring disease progression with hpv cfdna in head and neck cancer
-
1:21
what is the future of hpv-positive and hpv-negative head and neck cancer management?
-
1:21
response-adaptive treatment de-escalation in patients with hpv oropharyngeal cancer
-
3:52
variations of hpv in head and neck across the world
-
1:13
radiation and adjuvant nivolumab in hpv oropharynx cancer
-
1:03
erin mcmenamin, msn, on hpv-related head & neck cancer prognosis